Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Günter Emons

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Oncology Research and Treatment|September 19, 2014
Significance of lymph node dissection in gynecological oncologyGünter Emons
Cells|January 8, 2023
Hormone-Dependent Cancers: Molecular Mechanisms and Therapeutical ImplicationsGünter Emons
Cells|March 6, 2021
Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian CancerCarsten Gründker, Günter Emons
Reproductive Biology and Endocrinology : RB&E|November 5, 2003
Role of gonadotropin-releasing hormone (GnRH) in ovarian cancerCarsten Gründker, Günter Emons
Cells|February 4, 2021
The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial CancerGünter Emons, Carsten Gründker
Current Opinion in Oncology|June 25, 2019
Adjuvant treatment for endometrial cancerGünter Emons, Dirk Vordermark
Frontiers in Endocrinology|August 22, 2017
The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and MetastasisCarsten Gründker, Günter Emons
Oncology Letters|May 29, 2018
Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiolRainer Girgert, Günter Emons, Carsten Gründker
BMC Cancer|December 16, 2014
Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiolRainer Girgert, Günter Emons, Carsten Gründker
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 17, 2012
Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapiesMadita Reutter, Günter Emons, Carsten Gründker
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Oncology Research and Treatment|September 19, 2014
Significance of lymph node dissection in gynecological oncologyGünter Emons
Cells|January 8, 2023
Hormone-Dependent Cancers: Molecular Mechanisms and Therapeutical ImplicationsGünter Emons
Cells|March 6, 2021
Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian CancerCarsten Gründker, Günter Emons
Reproductive Biology and Endocrinology : RB&E|November 5, 2003
Role of gonadotropin-releasing hormone (GnRH) in ovarian cancerCarsten Gründker, Günter Emons
Cells|February 4, 2021
The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial CancerGünter Emons, Carsten Gründker
Current Opinion in Oncology|June 25, 2019
Adjuvant treatment for endometrial cancerGünter Emons, Dirk Vordermark
Frontiers in Endocrinology|August 22, 2017
The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and MetastasisCarsten Gründker, Günter Emons
Oncology Letters|May 29, 2018
Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiolRainer Girgert, Günter Emons, Carsten Gründker
BMC Cancer|December 16, 2014
Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiolRainer Girgert, Günter Emons, Carsten Gründker
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 17, 2012
Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapiesMadita Reutter, Günter Emons, Carsten Gründker
Pageof 12